113 related articles for article (PubMed ID: 19261399)
21. "They're legal so they're safe, right?" What did the legal status of BZP-party pills mean to young people in New Zealand?
Sheridan J; Butler R
Int J Drug Policy; 2010 Jan; 21(1):77-81. PubMed ID: 19321329
[TBL] [Abstract][Full Text] [Related]
22. Metabolism and the urinary excretion profile of the recently scheduled designer drug N-Benzylpiperazine (BZP) in the rat.
Tsutsumi H; Katagi M; Miki A; Shima N; Kamata T; Nakajima K; Inoue H; Kishi T; Tsuchihashi H
J Anal Toxicol; 2006; 30(1):38-43. PubMed ID: 16620530
[TBL] [Abstract][Full Text] [Related]
23. Toxicity from the recreational use of 1-benzylpiperazine.
Gee P; Gilbert M; Richardson S; Moore G; Paterson S; Graham P
Clin Toxicol (Phila); 2008 Nov; 46(9):802-7. PubMed ID: 18821145
[TBL] [Abstract][Full Text] [Related]
24. Detection of 1-benzylpiperazine and 1-(3-trifluoromethylphenyl)-piperazine in urine analysis specimens using GC-MS and LC-ESI-MS.
Vorce SP; Holler JM; Levine B; Past MR
J Anal Toxicol; 2008; 32(6):444-50. PubMed ID: 18652752
[TBL] [Abstract][Full Text] [Related]
25. Disposition and metabolism of radiolabeled casopitant in humans.
Pellegatti M; Bordini E; Fizzotti P; Roberts A; Johnson BM
Drug Metab Dispos; 2009 Aug; 37(8):1635-45. PubMed ID: 19420128
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics, metabolism, and routes of excretion of intravenous irofulven in patients with advanced solid tumors.
Paci A; Rezai K; Deroussent A; De Valeriola D; Re M; Weill S; Cvitkovic E; Kahatt C; Shah A; Waters S; Weems G; Vassal G; Lokiec F
Drug Metab Dispos; 2006 Nov; 34(11):1918-26. PubMed ID: 16896064
[TBL] [Abstract][Full Text] [Related]
27. Acute effects of the designer drugs benzylpiperazine (BZP) and trifluoromethylphenylpiperazine (TFMPP) using functional magnetic resonance imaging (fMRI) and the Stroop task--a pilot study.
Curley LE; Kydd RR; Robertson MC; Pillai A; McNair N; Lee H; Kirk IJ; Russell BR
Psychopharmacology (Berl); 2015 Aug; 232(16):2969-80. PubMed ID: 25893641
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study.
Zhao RK; Cheng G; Tang J; Song J; Peng WX
Clin Ther; 2009 May; 31(5):1022-36. PubMed ID: 19539103
[TBL] [Abstract][Full Text] [Related]
29. The impact of New Zealand's 2008 prohibition of piperazine-based party pills on young people's substance use: results of a longitudinal, web-based study.
Sheridan J; Dong CY; Butler R; Barnes J
Int J Drug Policy; 2013 Sep; 24(5):412-22. PubMed ID: 23499366
[TBL] [Abstract][Full Text] [Related]
30. Acute effects of BZP, TFMPP and the combination of BZP and TFMPP in comparison to dexamphetamine on an auditory oddball task using electroencephalography: a single-dose study.
Lee H; Wang GY; Curley LE; Sollers JJ; Kydd RR; Kirk IJ; Russell BR
Psychopharmacology (Berl); 2016 Mar; 233(5):863-71. PubMed ID: 26630992
[TBL] [Abstract][Full Text] [Related]
31. Investigation of the first deaths in the United Kingdom involving the detection and quantitation of the piperazines BZP and 3-TFMPP.
Elliott S; Smith C
J Anal Toxicol; 2008 Mar; 32(2):172-7. PubMed ID: 18334102
[TBL] [Abstract][Full Text] [Related]
32. Differential responses to anticipation of reward after an acute dose of the designer drugs benzylpiperazine (BZP) and trifluoromethylphenylpiperazine (TFMPP) alone and in combination using functional magnetic resonance imaging (fMRI).
Curley LE; Kydd RR; Kirk IJ; Russell BR
Psychopharmacology (Berl); 2013 Oct; 229(4):673-85. PubMed ID: 23666554
[TBL] [Abstract][Full Text] [Related]
33. In vitro hepatotoxicity of 'Legal X': the combination of 1-benzylpiperazine (BZP) and 1-(m-trifluoromethylphenyl)piperazine (TFMPP) triggers oxidative stress, mitochondrial impairment and apoptosis.
Dias da Silva D; Silva MJ; Moreira P; Martins MJ; Valente MJ; Carvalho F; Bastos ML; Carmo H
Arch Toxicol; 2017 Mar; 91(3):1413-1430. PubMed ID: 27358233
[TBL] [Abstract][Full Text] [Related]
34. BZP-party pills: a review of research on benzylpiperazine as a recreational drug.
Cohen BM; Butler R
Int J Drug Policy; 2011 Mar; 22(2):95-101. PubMed ID: 21242080
[TBL] [Abstract][Full Text] [Related]
35. Pharmaceutical quality of "party pills" raises additional safety concerns in the use of illicit recreational drugs.
Young SA; Thrimawithana TR; Antia U; Fredatovich JD; Na Y; Neale PT; Roberts AF; Zhou H; Russell B
N Z Med J; 2013 Jun; 126(1376):61-70. PubMed ID: 23822962
[TBL] [Abstract][Full Text] [Related]
36. Dissociative and sympathomimetic toxicity associated with recreational use of 1-(3-trifluoromethylphenyl) piperazine (TFMPP) and 1-benzylpiperzine (BZP).
Wood DM; Button J; Lidder S; Ramsey J; Holt DW; Dargan PI
J Med Toxicol; 2008 Dec; 4(4):254-7. PubMed ID: 19031377
[TBL] [Abstract][Full Text] [Related]
37. Effect of continuous silymarin administration on oral talinolol pharmacokinetics in healthy volunteers.
Han Y; Guo D; Chen Y; Tan ZR; Zhou HH
Xenobiotica; 2009 Sep; 39(9):694-9. PubMed ID: 19555315
[TBL] [Abstract][Full Text] [Related]
38. Isotopic profiling of seized benzylpiperazine and trifluoromethylphenylpiperazine tablets using δ13C and δ15N stable isotopes.
Beckett NM; Cresswell SL; Grice DI; Carter JF
Sci Justice; 2015 Jan; 55(1):51-6. PubMed ID: 25577007
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics of conivaptan hydrochloride, a vasopressin V(1A)/V(2)-receptor antagonist, in patients with euvolemic or hypervolemic hyponatremia and with or without congestive heart failure from a prospective, 4-day open-label study.
Mao ZL; Stalker D; Keirns J
Clin Ther; 2009 Jul; 31(7):1542-50. PubMed ID: 19695403
[TBL] [Abstract][Full Text] [Related]
40. Multiorgan failure from 1-benzylpiperazine ingestion--legal high or lethal high?
Gee P; Jerram T; Bowie D
Clin Toxicol (Phila); 2010 Mar; 48(3):230-3. PubMed ID: 20184432
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
